Literature DB >> 33679941

Focal Segmental Glomerulosclerosis in Paediatric Population of South Punjab Pakistan: A Tertiary Care Hospital Experience.

Rabia Saleem Safdar1, M Faisal Mehar2, Afsheen Asghar Khan3, Nusrat Buzdar4.   

Abstract

OBJECTIVES: To find out frequency, clinicopathological features, response of treatment and outcome among children with primary focal segmental glomerulosclerosis (FSGS).
METHODS: This retrospective, non-interventional medical charts review study was conducted from a period of January 2011 to January 2020 at Pediatric Department of Nishtar Medical University Hospital, Multan, Pakistan. During the nine years study period, children of both genders, aged less than 16 years, with renal biopsies proven FSGS were included. Patient's demographic along with clinical and laboratory data, urine dipstick for proteinuria, renal functions, 24 hours urinary protein and ultrasonography findings of kidneys, ureters and bladder (KUB) were noted from case records. Response rates of various treatment options and their outcome like remission, partial remission, no remission with stable kidney disease & no remission with progression of kidney disease were noted.
RESULTS: During the study duration, out of 307 renal biopsies performed in glomerulonephritis cases, 124 (40.4%) had primary FSGS. In 124 primary FSGS cases, mean age was 8.83±3.05 years while most of the children, 70 (56.5%) were above 10 years of age. Majority of the cases, 64 (51.6%) were male. Mean follow up duration was noted to be 28.35+18.47 months. Most of the cases, 68 (54.8%) were found to have complete remission, 22 (17.7%) partial remission while 11 (8.9%) progressed to ESKD.
CONCLUSIONS: Among children, frequency of primary FSGS was high at our setting. Most of the cases achieved sustained remission rates with the help of immunosuppressive drugs. Cyclosporine and tacrolimus were found to be the most effective drugs. Copyright: © Pakistan Journal of Medical Sciences.

Entities:  

Keywords:  Complete remission; End stage kidney disease; Focal segmental glomerulosclerosis; Immunosuppressive drugs

Year:  2021        PMID: 33679941      PMCID: PMC7931269          DOI: 10.12669/pjms.37.2.3535

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


  22 in total

Review 1.  Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in children.

Authors:  Susan Samuel; Martin Bitzan; Michael Zappitelli; Allison Dart; Cherry Mammen; Maury Pinsk; Andrey V Cybulsky; Michael Walsh; Greg Knoll; Michelle Hladunewich; Joanne Bargman; Heather Reich; Atul Humar; Norman Muirhead
Journal:  Am J Kidney Dis       Date:  2014-01-11       Impact factor: 8.860

2.  Twenty-eight-year review of childhood renal diseases from renal biopsy data: A single centre in China.

Authors:  Mengjie Jiang; Zizheng Xiao; Liping Rong; Yuanyuan Xu; Lizhi Chen; Ying Mo; Liangzhong Sun; Wei Sun; Xiaoyun Jiang
Journal:  Nephrology (Carlton)       Date:  2016-12       Impact factor: 2.506

Review 3.  Idiopathic focal segmental glomerulosclerosis.

Authors:  H William Schnaper
Journal:  Semin Nephrol       Date:  2003-03       Impact factor: 5.299

4.  Pediatric focal segmental glomerulosclerosis in Jordan: A tertiary hospital experience.

Authors:  Reham I Almardini; Jumana H Albaramki; Ghazi M Al-Saliata; Mahdi Q Farah; Katibah H AlRabadi; Jawaher T Albderat
Journal:  Saudi J Kidney Dis Transpl       Date:  2018 Jul-Aug

5.  Role of immunoflourescence in the diagnosis of glomerulonephritis.

Authors:  Humaira Nasir; Sarah Chaudhry; Wajiha Raza; Ambreen Moatasim; Nadira Mamoon; Noreen Akhtar
Journal:  J Pak Med Assoc       Date:  2012-03       Impact factor: 0.781

6.  Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.

Authors:  Ashima Gulati; Aditi Sinha; Aarti Gupta; Madhuri Kanitkar; Vishnubhatla Sreenivas; Jyoti Sharma; Mukta Mantan; Indira Agarwal; Amit K Dinda; Pankaj Hari; Arvind Bagga
Journal:  Kidney Int       Date:  2012-07-04       Impact factor: 10.612

7.  Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.

Authors:  R Martinelli; L J Pereira; O M M Silva; A S Okumura; H Rocha
Journal:  Braz J Med Biol Res       Date:  2004-08-24       Impact factor: 2.590

Review 8.  Cyclosporine in the treatment of idiopathic nephrosis.

Authors:  P Niaudet; R Habib
Journal:  J Am Soc Nephrol       Date:  1994-10       Impact factor: 10.121

9.  [Clinical and histopathological characteristics of biopsy-proven renal diseases in Croatia].

Authors:  Danica Batinić; Mira Sćukanec-Spoljar; Danko Milosević; Mirna Subat-Dezulović; Marjan Saraga; Jasna Delmis; Zvonimir Puretić; Andrea Cvitkovic-Kuzmić; Natasa Skitarelić; Marija Spajic; Ljiljana Nizić; Kristina Vrljicak; Maja Matković; Hrvoje Kniewald; Danko Batinić; Lana Grković; Irena Borojević; Sanja Flajsman; Durdica Kosuljandić-Vukić; Semsa Marić; Danica Ljubanović
Journal:  Acta Med Croatica       Date:  2007-09

10.  A clinicopathologic study of primary focal segmental glomerulosclerosis in children.

Authors:  Ali Lanewala; Muhammed Mubarak; Javed Iqbal Kazi; Fazal Akhter; Atika Sher; Amir Fayyaz; Sajid Bhatti
Journal:  Saudi J Kidney Dis Transpl       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.